Saudi German Health
السعودي الألماني الصحيةTechnical Analysis & Signals
The Saudi German Health stock shows negative signals amid a downtrend and bearish patterns.
Technical Analysis
The stock is currently trading at 34.42 SAR, with the RSI at 40.5, indicating weakness in momentum. Additionally, the negative MACD Histogram crossover reinforces the likelihood of continued downtrend.
Support & Resistance Levels
The main support level is at 33.58 SAR, while resistance is at 37.22 SAR. The stock is expected to face difficulty breaking through the resistance level given the current downtrend.
Volume Analysis
Recent trading volume shows a decline, which may indicate weak demand for the stock. This decrease in volume could reflect a drop in investor confidence.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 8.4, which may indicate relatively low valuation. However, the 1.45% dividend yield might attract some investors despite current challenges.
Risk Factors
Potential risks include the company's financial performance decline, along with changes in the Saudi market and the TASI index. General economic conditions may negatively impact the stock price.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to monitor current trends and support/resistance levels before making any investment decisions.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - Saudi German Health
4009Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 3.17B
- P/E Ratio
- 8.40
- P/B Ratio
- 1.70
- EPS (Earnings/Share)
- 4.08
Profitability
- Revenue
- 3.13B
- Net Income
- 167.45M
- Return on Equity (ROE)
- 0.00%
- Shares Outstanding
- 92.04M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- N/A
- Debt/Equity
- 1.32
- Free Float %
- +44.3%
Dividends & Margins
- Dividend Yield
- +1.45%
- Dividend/Share
- 0.50
- Book Value
- 20.25
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
4 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2024 | 2.88B +8.7% | 282.00M +1555.1% | 5.13B -0.2% | 2.47B -0.8% | 3.06 +1510.5% |
| 2023 | 2.65B +23.3% | 17.04M -77.3% | 5.13B +14.1% | 2.49B +10.9% | 0.19 -76.8% |
| 2022 | 2.15B +14.9% | 75.18M +337.1% | 4.50B +13.2% | 2.24B +13.9% | 0.82 +331.6% |
| 2021 | 1.87B | 17.20M | 3.97B | 1.97B | 0.19 |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Saudi German Health launches ops at outpatient clinic complex in Riyadh
Saudi German Health sees revenue growth in 2026, margins to improve slightly: CEO
Saudi German Health board recommends buyback of up to 4.6M shares
Saudi German Health appoints Nezar Bahabri as CEO
AlJazira Capital issues Q4 2025 profit forecasts
SNB Capital sets Q4 2025 earnings estimates
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
TASI sees over 25 CEO resignations in 2025
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 224.60 SAR | |
| 4002 | Mouwasat | 66.50 SAR | |
| 4004 | Dallah Healthcare | 112.00 SAR | |
| 4017 | Fakeeh Care | 36.00 SAR | |
| 4018 | Almoosa | 129.50 SAR | |
| 4005 | CARE | 103.30 SAR | |
| 4019 | SMC Healthcare | 17.60 SAR | |
| 4007 | Alhammadi | 25.32 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-05-11
Risk Assessment
Risk Factors
Average True Range 4.4% of stock price
Trading volume below average
P/E ratio 8.4 — below average
Debt-to-equity ratio 1.32
ADX indicator at 25
High volatility and financial pressures requiring careful monitoring
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Saudi German Health stock price today?
Saudi German Health (4009) stock price today is 34.42 SAR, declining by -0.52% compared to the previous session close. The 52-week price range is between 28.66 SAR and 64.84 SAR.
2 What is Saudi German Health stock valuation?
The automated analysis signal for Saudi German Health is "Sell" with 65% confidence. The P/E ratio is 8.4. The P/B ratio is 1.70.
3 Is Saudi German Health Shariah-compliant?
Yes, Saudi German Health (4009) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Saudi German Health dividend distributions?
Saudi German Health has a dividend yield of 1.45%, with an estimated annual dividend of 0.50 SAR per share.
5 What is Saudi German Health weekly performance?
Saudi German Health performance over different time periods: weekly change -8.16%, monthly -4.28%, and year-to-date +4.43%. The stock is currently trading with a volume of 445,898 shares.
6 What is the target level for Saudi German Health?
According to automated analysis for Saudi German Health: Short-term target (1-2 weeks): 33.00 SAR. Support level: 33.58 SAR. Resistance level: 37.22 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.